Public BoD papers 28.04.22
Type of Research
Pre- Covid
Covid
Post- Covid
CTIMP) Other e.g observational, questionnaire
1855 2661
4107 4588
1449 2128
TOTAL number of patients
Table 5: NIHR Reported Performance in initiating clinical research and delivery Q2 21/22
Q3 21/22 21.5 days
Median days from date site confirmed (DSC) to date Site Selected (DSS) Median days from DSC to First Patient Recruited (FPR)
22 days
35.5 days
43 days
Median days DSS to FPR
73 days
81 days
Study Initiation
8 th position (of 185 trusts)
9 th position (of 189 trusts)
Recruiting to time and target
51.1%
51.1% (6 th position)
4. Ensure that R and I complies with all regulatory requirements governing research, provides assurance to funders and acts upon risks, audits and inspections CRF Strategic review action plan (November 2020) Action plan following review in November 2020 is monitored via management board Christie Charity Research A new assurance process for research and innovation related charitable fund investments has been established, reporting through to R and I Divisional Board.
Funding Assurance Including Academic Investment Plan NHSE Investigation ‘Christie Rapid Review’
A Task and Finish Group will be established within R and I to systematically address the recommendations to inform R and I Strategy Recommendations of the MHRA Inspection 2015 are not fully met and identified as high priority to address R and I Divisions will be subject to CQC Inspection. The Quality team is working on actions required to meet CQC Inspection criteria. • A SWOT analysis / review of current process is underway to inform quality improvement required for improved capacity and capability. • An action plan to ensure business continuity following the closure of the Manchester CTU is in place Actions to develop capacity and capability have commenced in collaboration with the new Director of Pharmacy, Damian Child Review of the current biobank model is underway due to reduced infrastructure funding 2022-2027 from CRUK Collaboration agreement is in discussion; Plans for occupation of the building by Christie staff have been presented at the Paterson Redevelopment Project Synergy and Steering Board Meetings.
MHRA Inspection Readiness CQC Inspection Readiness Christie Sponsored Research
Pharmacy research delivery
Manchester Cancer Research Centre Biobank
MCRC and Paterson Redevelopment
65
Made with FlippingBook flipbook maker